In acardia, the acardiac twin may present with various degrees of underdevelopment, often lacking other vital organs and structures. The pump twin, however, may exhibit signs of heart failure due to the increased cardiac workload required to support the acardiac twin through shared placental circulation. Symptoms in the pump twin can include fluid overload, heart enlargement, and signs of distress in utero.

The diagnosis of acardia is typically made through prenatal ultrasound, which can reveal the absence of cardiac activity in one twin and the presence of an underdeveloped body. Doppler studies may be used to assess blood flow patterns, confirming the presence of TTTS. Regular monitoring of the pump twin's heart function and overall health is crucial to manage the condition effectively.

Treatment focuses on protecting the pump twin. Options may include selective reduction of the acardiac twin to alleviate the burden on the pump twin's heart. This can be achieved through procedures like radiofrequency ablation or laser coagulation of the vessels connecting the twins. Close monitoring and timely intervention are essential to improve outcomes for the pump twin.

The prognosis for the acardiac twin is invariably poor, as survival without a heart is impossible. However, with appropriate intervention, the pump twin can have a favorable outcome. The success of treatment largely depends on the timing of diagnosis and intervention, as well as the severity of the condition.

Acardia results from abnormal vascular connections between monochorionic twins, leading to an imbalance in blood flow. The acardiac twin receives blood from the pump twin through these connections, bypassing the need for its own heart. This abnormal circulation pattern prevents normal cardiac development in the acardiac twin.

Acardia is an extremely rare condition, occurring in approximately 1 in 35,000 pregnancies. It is exclusively associated with monochorionic twin pregnancies, which themselves account for about 20% of all twin pregnancies. The rarity of the condition makes it a challenging diagnosis for clinicians.

The pathophysiology of acardia involves the disruption of normal embryonic development due to abnormal blood flow patterns. The acardiac twin relies on the pump twin for circulation, leading to underdevelopment of the heart and other organs. This places a significant strain on the pump twin's cardiovascular system, potentially leading to heart failure if left untreated.

Preventing acardia is challenging due to its congenital nature. However, early detection through routine prenatal care and ultrasound can help manage the condition more effectively. In cases of monochorionic twin pregnancies, close monitoring for signs of TTTS can aid in early intervention and improve outcomes for the pump twin.

Acardia is a rare and severe form of twin-to-twin transfusion syndrome characterized by the absence of a functional heart in one twin. While the condition is fatal for the acardiac twin, timely intervention can significantly improve the prognosis for the pump twin. Early diagnosis and careful monitoring are crucial in managing this complex condition.

For expectant parents, learning about acardia can be overwhelming. It is important to understand that this condition is rare and occurs only in certain types of twin pregnancies. Regular prenatal check-ups and ultrasounds are vital for early detection. If diagnosed, a team of specialists will work to ensure the best possible outcome for the healthy twin.